Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Medical Virology L1-10 > HCV > Flashcards

HCV Flashcards

(59 cards)

Start Studying
1
Q

Worldwide distribution of HCV

A

185 million chronic carriers 75% of cases become chronic
HCV is the leading chronic liver disease cirrhosis and HCC and the leading indication for liver transplantation in many countries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Risk factors of HCV

A

Frequent exposure to blood is the most important

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

HCV to acute/chronic hep

A 
Acute hepatitis (10-30%) to recovery 
Chronic hepatitis (70-90% dependent on county) --> HCC (2.5% of chronic patients) 
100 people infected 
75-85 = chronic
60-70 = CLD 
5 - 29 = cirrhosis
1 - 5 = liver cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Time frame of HCV

A

Acute hepatitis 0-24 weeks
Chronic hepatitis 24-50 years
Liver cirrhosis and HCC 10-40 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

When was HCV first identified?

A

1989

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Where did the NANB hepatitis infectious agent

A

Could infect chimps and cause chronic liver disease and cirrhosis
Only 5% of people realise they have it and can go 20 years undiagnosed
Acute disease, mild compared to HBV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

When was the HCV genome sequenced?

A

1991

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Sources of HCV infection

A 
Sources of infections:
Injecting drug use 60% 
Sexual 15% 
Transfusion (before screening) 10% 
Occupational 4% 
T
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How many HCV genotypes are there

A

6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What type of virus is HCV?

A

An RNA virus with a very plastic genome and is prone to change
Lots of research done genotype 1 (drugs etc specific to genotype) however more recent drugs against the majority of the genotypes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Replication of HCV

A

HCV infections are generally Parenteral
HCV spreads through the bloodstream to the liver - the primary target for replication
Viral half life is around 2-3 hours/1012 visions/ day if chronic
Liver contains the highest levels of HCV RNA
But only 5-19% of hepatocytes HCV RNA positive
1-5% of liver mononuclear cells express HCV antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

The hepatic HCV innate immune response fails to mount

A

A productive immune rapidness that clears the infection. HCV has several mechanisms to evade the immune response - chronic infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Therapy for HCV

A

Pegylated IFN α + ribavirun 40-50% curative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The HCV virion morphology

A

Associations with LDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

HCV infections does what to IFNL3 (IL28β)

A

Leads to polymorphisms which can influence the outcome of infection and therapy response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

HCV genome has what elements?

A

IRES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Component of HCV genome and how is it transcribed?

A

As a polyprotein
C - core immediately wraps around genome, E1 & E2 - envelope protein (heavily glycosylated), p7 associates with NS2 in the membrane, NS2 - protease, NS3(A serine protease cofactor) - serine protease and a helicase, NS4B - membranous web, NS5A - ?, NS5B - RdepRpol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How is the HCV viral positive sense RNA genomes translated?

A

As a single polyprotein that is co and post translationly modified by host peptidases and 2 virally encoded proteases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What do HCV no structural proteins do?

A

They assemble as a peplication complex onto modified intracellular membranes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What intermediates are made in HCV

A

Anti genomic replication intermediate RNA and likely accumulation of dsRNA intermediates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How is HCV recognised by the immune system

A

HCV is recognised as non-self by PRRs that bind to PAMPs of the viral products - adaptive and innate immune activation (although this does not self like self)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is HCV virus associated with when it leaves the cell?

A

In association with host lipoproteins so HCV is present as a lipoprotein coated virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

How does HCV enter into the cell

A 
Via heparin sulphate proteoglycans 
Low density lipoprotein receptor
SRBP1 - scavenger receptor class B member 1 
Claudin 1 
Occludins

Lots of receptors to help the entry of the virus into the cell. Initially receptors are not specific to the virus, no single one lets the virus into the cell but a whole group of them together.
Enters via clatherin mediated endocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Look at the early and late events in the virus lifecycle and learn the images

Study These Flashcards
A

Page 22/23 HCV

25
What can be used as a selectable market in an engineered viral cDNA plasmid and what is removed?
Neomycin resistance | Removal of structural genes
26
What's a very virulent strain of HCV?
SGR-JFH1
27
HCV clinical features
``` Incubation period - 6-7 weeks Acute illness - mild Case fatality rate - low Chronic infection - 75-85% Chronic hepatitis - 70% Cirrhosis - 10-20% Mortality from chronic liver disease 1-5% (occasional very aggressive strain) ```
28
What marker can be used to view clinical response and liver damage to HCV?
ALT alanine amino- transferase Market of liver damage
29
What factors promote progression or severity of chronic HCV
``` Infection from blood transfusion Increase alcohol intake Age >40 at time of infection HIV co-infection Genetic background Others? Male gender or other co-infection HBV ```
30
In the UK HOW MANY HCC cases are caused by HCV?
30%
31
In HCV what does HCC follow?
Chronic inflammation, necrosis, regeneration and cirrhosis
32
In vivo the mechanisms of oncogenesis in HCV has not been discovered. How is it described in vitro
Core: can protect cells against apoptosis (transgenic mice expressing core developed primary liver cancer) NS3: expression can lead to cellular transformation NS5A: contains a transcription transactivation domain
33
HCV suppresses and evades the immune system: innate:
In the cell Infection blocks IFNα release which normally activates the innate immune response. (No NKT cell act) Extra cellular: HCV directly inhibits NK cells as well as DCs that promote adaptive immunity
34
HCV suppresses and evades the immune system: adaptive
DCs are inhibited and the overall B and T cell response is weakened. B cells: Mutant HCV strains elude antibody recognition HCV elicits interfering antibodies that prevent binding of neutralising antibodies T cells: HCV directly and indirectly suppresses activation of killer T cells HCV mutation yields epitopes that escape recognition HCV transmission from liver cell to liver cell evades antibodies
35
HCV induces what what in the innate response?
Interferon response and also attenuate the IFN response
36
How does HCV affect the IFN response?
Core: inhibition of stat1 and increased expression of SOCa proteins NS5A: General attenuation of IFN expression inhibitors of PKR NS3/4A cleaves the polyprotein and also cleaves MAVs and TRIF preventing IRF3 pathway activation and as a result no IFNα/β production
37
What TLR does HCV bind to and what other mechanism is it recognised by?
TLR3 binding | And dsRNA
38
Acutely infected HCV patients produces antibodies against?
Epitopes that are structural and non structural but most have no relevant antiviral activity and only a small number inhibit binding, entry of uncoating
39
What is associated with spontaneous resolution of acute hcv?
Certain defined HLA I alleles HLA -A3, -B27 and -Cw*01 - clear HLA-B8 - persistence
40
What does the protective effect of HLA-b27 require?
Presence of genotype specific immuno dominant CD8 T cell epitope. Thus preventing the viruses dominant role of a specific CD8 T cell response (elicited through IFNγ non cytopathic effector function)
41
What may lead to HCV escape from antibody?
Quasispecies development | Interaction with HDL and SCARB1
42
What is the role of CD4 cells in HCV infection?
They are central regulators Acute infections associated with a vigorous multi-specific helper T cell response intensity, epitope specifics and cytokine profile of the T cell response during early infection appear to be predictive of viral clearance and recovery
43
In acute HCV infection what type of cd4 response is there?
Strong multi specific and sustained associated with limited course of infection
44
What HLA II are assoc with positive outcome of acute HCV?
DRB1*1101 and DRB1*0301
45
If cd8s are depleted by antibodies in chinos what happens in HCV?
Persistence until HCV response is recovered and an HCV specific cd8 T cell response emerges showing cd8 cells are most like the key effectors in HCV control
46
Th2 response is predominant in what type of HCV infection?
Chronic
47
What th1 cytokines are required for HCV clearance?
Il2 and IFNγ
48
CD8 in HCV pathogenisis (4)
Vigorous multi specific CTL response in acute infection CTL epitopes identified of all viral proteins Frequent of CTL epitopes much higher in the liver than the peripheral blood but still not enough to clear the virus in chronic infections Balance between stronger CTL response and liver damage
49
When do HCV antibodies appear?
7-31 weeks after infection
50
What viral protein is the major target for neutralising antibodies and for vaccine?
HVR of E2 which has high sequence variability influenced by host immune pressure
51
Are antibodies protective against HCV?
Difficult to tell without routine cell culture Early response to E2 HRV may be assoc with clearance of HCV Resolution on HCV can occur without antibody production (chimps) and seroconversion (humans) Patients who recover do not seem to be immune from reinfection
52
How does the immune response to HCV cause liver damage?
By immune recognition and destruction of infected hepatocytes Persistent HCV infection triggers an active T cell response & liver lesions over time. (FasL induced apop of hepatocytes, TNFα and perforin based mechanisms of cells destruction)
53
What are preferentially attracted to HCV infected livers?
Th1 cells - cytokines may enhance necro-inflammatory lesions
54
What is the mutation rate of HCV?
1 in 10 euros every time it replicates | Which results in the rapid evolution of viral quasispecies
55
Consensus sequence is?
The average sequence of all the viral quasispecies with all the varying mutations in the genome.
56
If you develop a drug against a specific consensus sequence what happens?
There will be a shift in the viral quasispecies that exist.
57
Three hypotheses as to why HCV persists
1. Once a persistent infection is established, the immune response is too weak to clear the infection 2. HCV proteins may actively suppress the immune response 3. Viral genetic variation
58
Treatment of HCV involves
Pegylates IFNα and ribavrin for those at risk of progression to cirrhosis
59
What does the success of the anti-HCV therapeutics rely on?
HCV genotype, initial viral load, prior liver damage, age, gender. Patients may feel fine and then get very ill

Medical Virology L1-10 (2 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions